Table 5.
Mortality trends due to selected cardiovascular diseases in Poland in 2008–2017 by gender and age
| Variable | Mortality trends | |||||||
|---|---|---|---|---|---|---|---|---|
| women | men | |||||||
| year | years of change | AAPC (95% CI) | APC (95% CI) | year | years of change | AAPC (95% CI) | APC (95% CI) | |
| Ischemic heart diseases | ||||||||
| 20–24 years | 2008–2017 | 0 | 0 | 2008–2017 | 0.1 (–12.3–14.2) | 0.1 (–12.3–14.2) | ||
| 25–29 years | 2008–2017 | 0 | 0 | 2008–2017 | –6.2 (–16.6–5.5) | –6.2 (–16.6–5.5) | ||
| 30–34 years | 2008–2017 | –14.6* (–24.0–(–4.0)) | –14.6* (–24.0–(–4.0)) | 2008–2017 | –8.8* (–15.9–(–1.1)) | |||
| 2008–2013 | 2013 | –15.9* (–25.9–(–4.6)) | ||||||
| 2013–2017 | 1.1 (–15.5–20.9) | |||||||
| 35–39 years | 2008–2017 | –8.6* (–14.5–(–2.3)) | –8.6* (–14.5–(–2.3)) | 2008–2017 | –10.9* (–13.8–(–7.9)) | –10.9* (–13.8–(–7.9)) | ||
| 40–44 years | 2008–2017 | –9.8* (–12.4–(–7.1)) | –9.8* (–12.4–(–7.1)) | 2008–2017 | –10.9* (–12.7–(–9.0)) | –10.9* (–12.7–(–9.0)) | ||
| 45–49 years | 2008–2017 | –5.4* (–10.1–(–0.6)) | –5.4* (–10.1–(–0.6)) | 2008–2017 | –7.1* (–8.2–(–6.1)) | –7.1* (–8.2–(–6.1)) | ||
| 50–54 years | 2008–2017 | –5.7* (–7.4–(–4.1)) | –5.7* (–7.4–(–4.1)) | 2008–2017 | –5.8* (–6.8–(–4.7)) | –5.8* (–6.8–(–4.7)) | ||
| 55–59 years | 2008–2017 | –3.3* (–4.4–(–2.2)) | –3.3* (–4.4–(–2.2)) | 2008–2017 | –4.3* (–5.0–(–3.6)) | –4.3* (–5.0–(–3.6)) | ||
| 60–64 years | 2008–2017 | –4.0* (–5.2–(–2.9)) | –4.0* (–5.2–(–2.9)) | 2008–2017 | –4.0* (–4.7–(–3.3)) | –4.0* (–4.7–(–3.3)) | ||
| Cerebrovascular disease | ||||||||
| 20–24 years | 2008–2017 | –3.9 (–13.1–6.2) | –3.9 (–13.1–6.2) | 2008–2017 | –4.3 (–12.1–4.1) | –4.3 (–12.1–4.1) | ||
| 25–29 years | 2008–2017 | –3.6 (–8.2–1.3) | –3.6 (–8.2–1.3) | 2008–2017 | –2.5 (–7.2–2.5) | –2.5 (–7.2–2.5) | ||
| 30–34 years | 2008–2017 | –3.6 (–7.9–0.8) | –3.6 (–7.9–0.8) | 2008–2017 | –4.0 (–9.7–2.0) | |||
| 2008–2011 | 2011 | –13.8 (–29.3–5.1) | ||||||
| 2011–2017 | 1.3 (–5.2–8.3) | |||||||
| 35–39 years | 2008–2017 | –2.4 (–6.5–1.7) | –2.4 (–6.5–1.7) | 2008–2017 | –5.0* (–7.6–(–2.5)) | –5.0* (–7.6–(–2.5)) | ||
| 40–44 years | 2008–2017 | –7.2* (–9.8–(–4.5)) | –7.2* (–9.8–(–4.5)) | 2008–2017 | –6.4* (–7.8–(–5.0)) | –6.4* (–7.8–(–5.0)) | ||
| 45–49 years | 2008–2017 | –6.2* (–8.5–(–3.9)) | –6.2* (–8.5–(–3.9)) | 2008–2017 | –5.9* (–7.7–(–4.2)) | –5.9* (–7.7–(–4.2)) | ||
| 50–54 years | 2008–2017 | –6.6* (–7.8–(–5.5)) | –6.6* (–7.8–(–5.5)) | 2008–2017 | –5.4* (–6.1–(–4.8)) | –5.4* (–6.1–(–4.8)) | ||
| 55–59 years | 2008–2017 | –5.4* (–6.9–(–3.8)) | 2008–2017 | –5.8* (–6.7–(–4.9)) | –5.8* (–6.7–(–4.9)) | |||
| 2008–2015 | 2015 | –6.7* (–7.8–(–5.6)) | ||||||
| 2015–2017 | –0.5 (–8.9–8.7) | |||||||
| 60–64 years | 2008–2017 | –6.0* (–7.3–(–4.7)) | 2008–2017 | –4.6* (–5.6–(–3.6)) | –4.6* (–5.6–(–3.6)) | |||
| 2008–2013 | 2013 | –3.8* (–5.9–(–1.7)) | ||||||
| 2013–2017 | –8.6* (–11.4–(–5.8)) | |||||||
| Atherosclerosis | ||||||||
| 20–24 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 25–29 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 30–34 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 35–39 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 40–44 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 45–49 years | 2008–2017 | 0 | 0 | 2008–2017 | –22.4* (–39.4–(–0.7)) | –22.4* (–39.4–(–0.7)) | ||
| 50–54 years | 2008–2017 | –19.6 (–32.6–(–4.0)) | –19.6 (–32.6–(–4.0)) | 2008–2017 | –20.4* (–32.0–(–6.9)) | –20.4* (–32.0–(–6.9)) | ||
| 55–59 years | 2008–2017 | –5.5 (–16.1–6.3) | –5.5 (–16.1–6.3) | 2008–2017 | –14.4 (–32.7–8.9) | –14.4 (–32.7–8.9) | ||
| 60–64 years | 2008–2017 | –3.0 (–6.9–1.2) | –3.0 (–6.9–1.2) | 2008–2017 | –2.1 (–6.5–2.5) | –2.1 (–6.5–2.5) | ||
| Aortic aneurysm | ||||||||
| 20–24 years | 2008–2017 | 0 | 0 | 2008–2017 | 0 | 0 | ||
| 25–29 years | 2008–2017 | 0 | 0 | 2008–2017 | –2.9 (–12.6–7.8) | –2.9 (–12.6–7.8) | ||
| 30–34 years | 2008–2017 | 0 | 0 | 2008–2017 | 0.0 (–8.1–8.8) | 0.0 (–8.1–8.8) | ||
| 35–39 years | 2008–2017 | 0 | 0 | 2008–2017 | –4.9 (–12.5–3.4) | –4.9 (–12.5–3.4) | ||
| 40–44 years | 2008–2017 | –1.5 (–15.6–14.9) | –1.5 (–15.6–14.9) | 2008–2017 | –3.5 (–12.9–6.9) | –3.5 (–12.9–6.9) | ||
| 45–49 years | 2008–2017 | 0.1 (–13.4–15.7) | 0.1 (–13.4–15.7) | 2008–2017 | –6.6* (–9.9–(–3.0)) | –6.6* (–9.9–(–3.0)) | ||
| 50–54 years | 2008–2017 | –8.8* (–15.1–(–2.0)) | –8.8* (–15.1–(–2.0)) | 2008–2017 | –4.4* (–8.0–(–0.6)) | –4.4* (–8.0–(–0.6)) | ||
| 55–59 years | 2008–2017 | –6.6* (–11.1–(–1.8)) | –6.6* (–11.1–(–1.8)) | 2008–2017 | –5.7* (–8.0–(–3.3)) | –5.7* (–8.0–(–3.3)) | ||
| 60–64 years | 2008–2017 | –2.2 (–6.1–1.8) | –2.2 (–6.1–1.8) | 2008–2017 | –3.6* (–5.7–(–1.4)) | –3.6* (–5.7–(–1.4)) | ||
Abbreviation as in Table 4.
Year of change points out a year in which a significant change of mortality time trend was observed.
*
The significant values were marked at p < 0.05.